Authors:
Kelland, LR
Smith, V
Valenti, M
Patterson, L
Clarke, PA
Detre, S
End, D
Howes, AJ
Dowsett, M
Workman, P
Johnston, SRD
Citation: Lr. Kelland et al., Preclinical antitumor activity and pharmacodynamic studies with the farnesylprotein transferase inhibitor R115777 in human breast cancer, CLIN CANC R, 7(11), 2001, pp. 3544-3550
Authors:
Hostein, I
Robertson, D
DiStefano, F
Workman, P
Clarke, PA
Citation: I. Hostein et al., Inhibition of signal transduction by the Hsp90 inhibitor 17-allylamino-17-demethoxygeldanamycin results in cytostasis and apoptosis, CANCER RES, 61(10), 2001, pp. 4003-4009
Authors:
Andreyev, HJN
Norman, AR
Cunningham, D
Oates, J
Dix, BR
Iacopetta, BJ
Young, J
Walsh, T
Ward, R
Hawkins, N
Beranek, M
Jandik, P
Benamouzig, R
Jullian, E
Laurent-Puig, P
Olschwang, S
Muller, O
Hoffmann, I
Rabes, HM
Zietz, C
Troungos, C
Valavanis, C
Yuen, ST
Ho, JWC
Croke, CT
O'Donoghue, DP
Giaretti, W
Rapallo, A
Russo, A
Bazan, V
Tanaka, M
Omura, K
Azuma, T
Ohkusa, T
Fujimori, T
Ono, Y
Pauly, M
Faber, C
Glaesener, R
de Goeij, AFPM
Arends, JW
Andersen, SN
Lovig, T
Breivik, J
Gaudernack, G
Clausen, OPF
De Angelis, P
Meling, GI
Rognum, TO
Smith, R
Goh, HS
Font, A
Rosell, R
Sun, XF
Zhang, H
Benhattar, J
Losi, L
Lee, JQ
Wang, ST
Clarke, PA
Bell, S
Quirke, P
Bubb, VJ
Piris, J
Cruickshank, NR
Morton, D
Fox, JC
Al-Mulla, F
Lees, N
Hall, CN
Snary, D
Wilkinson, K
Dillon, D
Costa, J
Pricolo, VE
Finkelstein, SD
Thebo, JS
Senagore, AJ
Halter, SA
Wadler, S
Malik, S
Krtolica, K
Urosevic, N
Citation: Hjn. Andreyev et al., Kirsten ras mutations in patients with colorectal cancer: the 'RASCAL II' study, BR J CANC, 85(5), 2001, pp. 692-696
Authors:
Clarke, PA
Poele, RT
Wooster, R
Workman, P
Citation: Pa. Clarke et al., Gene expression microarray analysis in cancer biology, pharmacology, and drug development: progress and potential, BIOCH PHARM, 62(10), 2001, pp. 1311-1336
Authors:
Clarke, PA
Hostein, I
Banerji, U
Di Stefano, F
Maloney, A
Walton, M
Judson, I
Workman, P
Citation: Pa. Clarke et al., Gene expression profiling of human colon cancer cells following inhibitionof signal transduction by 17-allylamino-17-demethoxygeldanamycin, an inhibitor of hsp90 molecular chaperone, ONCOGENE, 19(36), 2000, pp. 4125-4133
Authors:
Waters, JS
Webb, A
Cunningham, D
Clarke, PA
Raynaud, F
di Stefano, F
Cotter, FE
Citation: Js. Waters et al., Phase I clinical and pharmacokinetic study of Bcl-2 antisense oligonucleotide therapy in patients with non-Hodgkin's lymphoma, J CL ONCOL, 18(9), 2000, pp. 1812-1823
Authors:
Watson, SA
Clarke, PA
Morris, TM
Caplin, ME
Citation: Sa. Watson et al., Antiserum raised against an epitope of the cholecystokinin B/gastrin receptor inhibits hepatic invasion of a human colon tumor, CANCER RES, 60(20), 2000, pp. 5902-5907
Authors:
Watson, SA
Michaeli, D
Grimes, S
Morris, TM
Varro, A
Clarke, PA
Smith, AM
Justin, TA
Hardcastle, JD
Citation: Sa. Watson et al., A comparison of an anti-gastrin antibody and cytotoxic drugs in the therapy of human gastric ascites in SCID mice, INT J CANC, 81(2), 1999, pp. 248-254
Authors:
Ronen, SM
DiStefano, F
McCoy, CL
Robertson, D
Smith, TAD
Al-Saffar, NM
Titley, J
Cunningham, DC
Griffiths, JR
Leach, MO
Clarke, PA
Citation: Sm. Ronen et al., Magnetic resonance detects metabolic changes associated with chemotherapy-induced apoptosis, BR J CANC, 80(7), 1999, pp. 1035-1041